Chinook Therapeutics, Inc.
KDNYDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001435049
Chinook Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 185 institutions reported holding it in 13F filings for Q2 2023, worth $2.24B in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Chinook Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- +31 vs. Q1 2022
- Shares held
- 53.5M
- +9.02M (+20.3%) vs. Q1 2022
- Total value
- $930.3M
- +$203.0M (+27.9%) vs. Q1 2022
- New holders
- 43
- 56 more added
- Sold out
- 12
- 25 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KDNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 2 | $0 |
| Q2 2023 | 185 | $2.24B |
| Q1 2023 | 157 | $1.42B |
| Q4 2022 | 155 | $1.52B |
| Q3 2022 | 151 | $1.12B |
| Q2 2022 | 135 | $930.3M |
| Q1 2022 | 105 | $727.3M |
| Q4 2021 | 103 | $707.4M |
| Q3 2021 | 85 | $361.6M |
| Q2 2021 | 89 | $372.0M |
| Q1 2021 | 77 | $366.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Chinook Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Invesco Ltd. | 346,654 | $6.06M | 0.00% | +315,755+1,021.9% | Added |
| FMR LLC | 354,834 | $6.21M | 0.00% | −214,339−37.7% | Reduced |
| Northern Trust Corp | 388,507 | $6.79M | 0.00% | +38,217+10.9% | Added |
| Woodline Partners LP | 401,023 | $7.01M | 0.11% | +401,023 | New |
| VR Adviser, LLC | 489,618 | $8.56M | 1.69% | −794,203−61.9% | Reduced |
| Driehaus Capital Management LLC | 492,303 | $8.61M | 0.14% | +492,303 | New |
| Baillie Gifford & Co | 504,825 | $8.83M | 0.01% | −306,054−37.7% | Reduced |
| Rock Springs Capital Management LP | 507,512 | $8.88M | 0.26% | −192,837−27.5% | Reduced |
| Nicholas Investment Partners, LP | 549,854 | $9.62M | 0.91% | +410,036+293.3% | Added |
| Altium Capital Management LP | 615,000 | $10.8M | 4.55% | +70,000+12.8% | Added |
| Nuveen Asset Management, LLC | 625,204 | $10.9M | 0.00% | +410,711+191.5% | Added |
| Sphera Funds Management Ltd. | 643,731 | $11.3M | 2.14% | +150,054+30.4% | Added |
| EcoR1 Capital, LLC | 690,000 | $12.1M | 0.42% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 796,460 | $13.9M | 5.92% | −85,893−9.7% | Reduced |
| Laurion Capital Management LP | 829,750 | $14.5M | 0.61% | +75,000+9.9% | Added |
| Geode Capital Management, LLC | 830,074 | $14.5M | 0.00% | +53,008+6.8% | Added |
| Dimensional Fund Advisors LP | 832,406 | $14.6M | 0.01% | +311,931+59.9% | Added |
| Candriam Luxembourg S.C.A. | 871,155 | $15.2M | 0.13% | −314,159−26.5% | Reduced |
| Vivo Capital, LLC | 872,151 | $15.3M | 1.53% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 937,568 | $16.4M | 8.98% | +92,413+10.9% | Added |
| Rubric Capital Management LP | 949,166 | $16.6M | 0.87% | +384,813+68.2% | Added |
| Assenagon Asset Management S.A. | 1,061,882 | $18.6M | 0.08% | +1,061,882 | New |
| Millennium Management LLC | 1,185,233 | $20.7M | 0.03% | +448,094+60.8% | Added |
| State Street Corp | 1,552,941 | $27.2M | 0.00% | −44,061−2.8% | Reduced |
| Suvretta Capital Management, LLC | 1,784,200 | $31.2M | 1.19% | +350,000+24.4% | Added |
| OrbiMed Advisors LLC | 1,896,300 | $33.2M | 0.64% | +478,000+33.7% | Added |
| Vanguard Group Inc | 2,362,576 | $41.3M | 0.00% | +533,204+29.1% | Added |
| Point72 Asset Management, L.P. | 2,419,099 | $42.3M | 0.20% | +1,164,899+92.9% | Added |
| Baker Bros. Advisors LP | 2,534,102 | $44.3M | 0.25% | +200,000+8.6% | Added |
| Octagon Capital Advisors LP | 2,551,703 | $44.6M | 11.91% | +1,195,453+88.1% | Added |
| BlackRock Inc. | 3,332,130 | $58.3M | 0.00% | +277,133+9.1% | Added |
| Deep Track Capital, LP | 3,430,110 | $60.0M | 4.15% | +430,110+14.3% | Added |
| Frazier Life Sciences Management, L.P. | 3,595,026 | $62.9M | 5.93% | +882,985+32.6% | Added |
| Samsara BioCapital, LLC | 5,161,888 | $90.3M | 24.14% | +570,000+12.4% | Added |
| International Biotechnology Trust PLC | 5,947 | – | – | −334,442−98.3% | Reduced |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −756,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −85,236−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −33,674−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −26,435−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,556−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −13,041−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −12,405−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −4,700−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,797−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |